Loading clinical trials...
Loading clinical trials...
Study to Determine Vaginal Colonization and Effect of an Oral Probiotic That Contains L.Rhamnosus, L. Plantarum and L. Crispatus in Women (PROSALVAG)
The aim of this study is to determine the efficacy of an oral nutraceutical with probiotics in restore vaginal health.
After being informed about the study, all patients meeting the inclusion/exclusion criteria and giving written informed consent will receive a nutraceutical containing L. rhamnosus, L. plantarum and L. crispatus once daily.
Age
35 - 43 years
Sex
FEMALE
Healthy Volunteers
Yes
HM Fertility Centter Vallés
Alcalá de Henares, Madrid, Spain
Start Date
October 11, 2021
Primary Completion Date
January 15, 2024
Completion Date
May 28, 2024
Last Updated
December 4, 2025
32
ACTUAL participants
FertyBiotic Balance
DIETARY_SUPPLEMENT
Lead Sponsor
Fertypharm
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06588218